Rituximab for the first-line treatment of stage III-IV follicular lymphoma (review of Technology Appraisal No. 110): Asystematic review and economic evaluation

D. Papaioannou*, R. Rafia, J. Rathbone, M. Stevenson, H. Buckley Woods, J. Stevens

*Corresponding author for this work

Research output: Contribution to journalArticleResearchpeer-review

19 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Rituximab for the first-line treatment of stage III-IV follicular lymphoma (review of Technology Appraisal No. 110): Asystematic review and economic evaluation'. Together they form a unique fingerprint.

Medicine & Life Sciences

Social Sciences